The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index, and 1 are not checked yet.
Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine
Open accessAbstract
Monamines subserve many critical roles in the brain, and monoaminergic drugs such as amphetamine have a long history in the treatment of neuropsychiatric disorders and also as a substance of abuse. The clinical effects of amphetamine are quite variable, from positive effects on mood and cognition in some individuals, to negative responses in others, perhaps related to individual variations in monaminergic function and monoamine system genes. We explored the effect of a functional polymorphism ( val 158 -met ) in the catechol O -methyltransferase gene, which has been shown to modulate prefrontal dopamine in animals and prefrontal cortical function in humans, on the modulatory actions of amphetamine on the prefrontal cortex. Amphetamine enhanced the efficiency of prefrontal cortex function assayed with functional MRI during a working memory task in subjects with the high enzyme activity val / val genotype, who presumably have relatively less prefrontal synaptic dopamine, at all levels of task difficulty. In contrast, in subjects with the low activity met / met genotype who tend to have superior baseline prefrontal function, the drug had no effect on cortical efficiency at low-to-moderate working memory load and caused deterioration at high working memory load. These data illustrate an application of functional neuroimaging in pharmacogenomics and extend basic evidence of an inverted-“U” functional-response curve to increasing dopamine signaling in the prefrontal cortex. Further, individuals with the met / met catechol O -methyltransferase genotype appear to be at increased risk for an adverse response to amphetamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that WM performance in psychotic and healthy subjects rely on dopamine levels within the PFC (Dumontheil et al., 2011; Mattay et al., 2003; Okubo et al., 1997).”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Mattay et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“some human participants who had lower baseline dopamine levels (due to Val/Val allele in COMT gene), showed improved WM performance after dexamphetamine administration, while others who had a higher dopamine level (met/met allele subjects) showed the opposite effect”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Mattay et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, methionine substitutions in COMT increase the stress response in mice75 and make humans more susceptible to cognitive impairment following stress and psychostimulant medication74.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [74]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the methionine substitution in the COMT protein that results from one of the COMT polymorphisms reduces the ability of COMT to catabolize dopamine and increases vulnerability to stress- or stimulant-induced working memory impairments in human subjects74 and in mice75.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurophysiological investigation of the basis of the fMRI signal
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001) · Nature · doi:10.1038/35084005 · Cited by 6,551
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citationModulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593
Allelic discrimination using fluorogenic probes and the 5' nuclease assay.
Livak, K. (1999) · Genetic Analysis, Techniques and Applications (GATA) · doi:10.1016/s1050-3862(98)00019-9 · Cited by 1,352
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Allelic discrimination using fluorogenic probes and the 5' nuclease assay
Foitzi, T. (1999) · Medical Entomology and Zoology · Cited by 783
Callicott, J. H. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.1.20 · Cited by 771
Self-citation
Research works printed but not linked: 1
- P Mannisto, S Kaakkola Pharmacol Rev 51, 593–628 (1999).
Cited by
Sorted by citations
Items 501–600 of 893
Zumárraga, M., Dávila, R., Basterreche, N., Arrúe, A., Goienetxea, B., Zamalloa, M. I., Erkoreka, L., Bustamante, S. E. Z., Inchausti, L., Torres, M. Á. G., et al. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.02.015 · Cited by 25
El-Hage, W., Phillips, M. L., Radua, J., Gohier, B., Zelaya, F. O., Collier, D. A., & Surguladze, S. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.145 · Cited by 24
Tipper, C. M., Cairo, T. A., Woodward, T. S., Phillips, A. G., Liddle, P. F., & Ngan, E. T. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0025-4 · Cited by 34
Caballero-Puntiverio, M., Lerdrup, L., Arvastson, L., Aznar, S., & Andreasen, J. T. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109823 · Cited by 23
Howarth, R., Adamson, A. M., Ashford, J. M., Merchant, T. E., Ogg, R. J., Schulenberg, S. E., Ogg, S. W., Li, J., Wu, S., Xiong, X., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24649 · Cited by 25
Bousman, C., Cherner, M., Atkinson, J. H., Heaton, R. K., Grant, I., Everall, I., & the HNRC Group (2010) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2010/678648 · Cited by 24
DRD2/CHRNA5 Interaction on Prefrontal Biology and Physiology during Working Memory
Giorgio, A. D., Smith, R. M., Fazio, L., D’Ambrosio, E., Gelao, B., Tomasicchio, A., Selvaggi, P., Taurisano, P., Quarto, T., Masellis, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095997 · Cited by 24
Genetic, Transcriptomic, and Epigenetic Studies of HIV-Associated Neurocognitive Disorder
Levine, A. J., Panos, S. E., & Horvath, S. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000069 · Cited by 24
Hohmann, S., Hohm, E., Treutlein, J., Blomeyer, D., Jennen-Steinmetz, C., Schmidt, M. H., Esser, G., Banaschewski, T., Brandeis, D., & Laucht, M. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.029 · Cited by 28
Association between genetic variation in the dopamine system and motor recovery after stroke
Kim, B.-R., Kim, H. Y., Chun, Y. I., Yun, Y., Kim, H.-T., Choi, D., & Lee, J. (2016) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-160667 · Cited by 25
Reed, J. L., D’Ambrosio, E., Marenco, S., Ursini, G., Zheutlin, A. B., Blasi, G., Spencer, B. E., Romano, R., Hochheiser, J., Reifman, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195189 · Cited by 26
Self-citationKozak, R., Kiss, T., Dlugolenski, K., Johnson, D. E., Gorczyca, R. R., Kuszpit, K. K., Harvey, B. D., Stolyar, P., Rizzo, S. J. S., Hoffmann, W. E., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01005 · Cited by 23
Levine, A. J., Reynolds, S. M., Cox, C., Miller, E. N., Sinsheimer, J. S., Becker, J. T., Martin, E. M., & Sacktor, N. C. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0241-y · Cited by 23
COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome
Shashi, V., Howard, T. D., Keshavan, M. S., Kaczorowski, J. A., Berry, M. N., Schoch, K., Spence, E. J., & Kwapil, T. R. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.048 · Cited by 24
Angelopoulou, E., Koros, C., Hatzimanolis, A., Stefanis, L., Scarmeas, N., & Papageorgiou, S. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052645 · Cited by 23
Children at risk for depression: Memory biases, self-schemas, and genotypic variation
Asarnow, L. D., Thompson, R. J., Joormann, J., & Gotlib, I. H. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.020 · Cited by 28
Humor as a Reward Mechanism: Event-Related Potentials in the Healthy and Diseased Brain
Mensen, A., Poryazova, R., Schwartz, S., & Khatami, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085978 · Cited by 27
The Role of Host Genetics in the Susceptibility for HIV-associated Neurocognitive Disorders
Levine, A. J., Singer, E. J., & Shapshak, P. (2008) · AIDS and Behavior · doi:10.1007/s10461-008-9360-x · Cited by 23
Tian, T., Qin, W., Liu, B., Wang, D., Wang, J., Jiang, T., & Yu, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078697 · Cited by 24
Towards Medication-Enhancement of Cognitive Interventions in Schizophrenia
Chou, H., Twamley, E. W., & Swerdlow, N. R. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_4 · Cited by 24
The relationship between dopamine receptor D1 and cognitive performance
Tsang, J., Fullard, J. F., Giakoumaki, S. G., Katsel, P., Katsel, P., Karagiorga, V. E., Greenwood, T. A., BRAFF, D. L., Siever, L. J., Bitsios, P., et al. (2015) · Schizophrenia · doi:10.1038/npjschz.2014.2 · Cited by 23
Moderate within-person variability in cortisol is related to executive function in early childhood
Blair, C., & Berry, D. J. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.03.026 · Cited by 24
Pharmacogenomics: an Update for Child and Adolescent Psychiatry
Namerow, L. B., Walker, S. A., Loftus, M., Bishop, J. R., Ruaño, G., & Malik, S. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01145-4 · Cited by 23
Effect of apomorphine on cognitive performance and sensorimotor gating in humans
Schellekens, A., Grootens, K. P., Neef, C., Movig, K. L. L., Buitelaar, J. K., Ellenbroek, B. A., & Verkes, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1686-1 · Cited by 22
Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia
Liao, S., Lin, S., Liu, C., Hsieh, M. H., Hwang, T., Liu, S., Guo, S., Hwu, H., & Chen, W. J. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00467.x · Cited by 22
Gender effects of the COMT Val158Met genotype on verbal fluency in healthy adults
Soeiro‐de‐Souza, M. G., Bio, D. S., David, D. P., Missio, G., LIMA, B., Fernandes, F. D. S., Machado‐Vieira, R., & Moreno, R. A. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1564 · Cited by 22
The COMT val158met polymorphism in ultra-endurance athletes
van Breda, K., Collins, M., Stein, D. J., & Rauch, L. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.07.039 · Cited by 22
Thompson, B. L., & Levitt, P. (2015) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-015-9131-8 · Cited by 23
Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults
Chou, H., Talledo, J., Lamb, S. N., Thompson, W. K., & Swerdlow, N. R. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2948-x · Cited by 24
Genetic variation in FGF20 modulates hippocampal biology
Lemaître, H., Mattay, V., Sambataro, F., Verchinski, B., Straub, R., Callicott, J., Kittappa, R., Hyde, T., Lipska, B., Kleinman, J., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5773-09.2010 · Cited by 24
Self-citationLapish, C. C., Ahn, K.-C., Chambers, R. A., Ashby, D. M., Ahn, S., & Phillips, A. G. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.23 · Cited by 21
Valomon, A., Holst, S. C., Borrello, A., Weigend, S., Müller, T. H., Berger, W., Sommerauer, M., Baumann, C. R., & Landolt, H. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0018-8 · Cited by 25
PCE Use in the Workplace: The Open Secret of Performance Enhancement
Leon, M. R., Harms, P. D., & Gilmer, D. O. (2018) · Journal of Management Inquiry · doi:10.1177/1056492618790091 · Cited by 22
Paroxetine influences respiration in rats: implications for the treatment of panic disorder
Olsson, M., Annerbrink, K., Bengtsson, F., Hedner, J. A., & Eriksson, E. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00044-0 · Cited by 24
Effects of Psychostimulants on Alertness and Spatial Bias in Healthy Participants
Dodds, C., Müller, U., & Manly, T. (2008) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2009.21046 · Cited by 22
Jongkees, B. J., Sellaro, R., Beste, C., Nitsche, M. A., Kühn, S., & Colzato, L. S. (2017) · Cortex · doi:10.1016/j.cortex.2017.02.014 · Cited by 21
RetractedDoes COMT genotype influence the effects of d‐amphetamine on executive functioning?
Wardle, M. C., Hart, A. B., Palmer, A. A., & de Wit, H. (2013) · Genes, Brain and Behavior · doi:10.1111/gbb.12012 · Cited by 29
Genes of the dopaminergic system selectively modulate top-down but not bottom-up attention
Schneider, K. K., Schote, A. B., Meyer, J., & Frings, C. (2014) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-014-0320-9 · Cited by 21
Willmott, C., Ponsford, J. L., McAllister, T. W., & Burke, R. (2013) · Brain Injury · doi:10.3109/02699052.2013.809553 · Cited by 21
Neuroimaging in Psychiatric Pharmacogenetics Research: The Promise and Pitfalls
Falcone, M., Smith, R. M., Chenoweth, M. J., Bhattacharjee, A. K., Kelsoe, J. R., Tyndale, R. F., & Lerman, C. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.152 · Cited by 21
Effect of d-amphetamine on post-error slowing in healthy volunteers
Wardle, M. C., Yang, A., & de Wit, H. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2462-6 · Cited by 21
Neuromodulation of behavioral and cognitive development across the life span.
Li, S. (2012) · Developmental Psychology · doi:10.1037/a0027813 · Cited by 20
Hintsanen, M., Elovainio, M. J., Puttonen, S., Mika Kivimaki, B., Lehtimäki, T. J., Kähönen, M. A. P., Juonala, M., Rontu, R., Viikari, J. S. A., Raitakari, O. T., et al. (2008) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e318165c7ec · Cited by 21
McCane, A. M., DeLory, M. J., Timm, M. M., Janetsian-Fritz, S. S., Lapish, C. C., & Czachowski, C. L. (2017) · Alcohol · doi:10.1016/j.alcohol.2017.08.007 · Cited by 18
Markett, S. A., Montag, C., Heeren, B., Sariyska, R., Lachmann, B., Weber, B., & Reuter, M. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1069-9 · Cited by 22
Lévy, F. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670601050432 · Cited by 22
Samek, D. R., Bailey, J. A., Hemphill, S. A., Wilson, S., Lee, S. S., Keyes, M. A., Epstein, M., Smolen, A., Miller, M. B., Winters, K. C., et al. (2016) · Behavior Genetics · doi:10.1007/s10519-016-9800-8 · Cited by 21
Zareyan, S., Zhang, H., Wang, J., Song, W., Hampson, E., Abbott, D., & Diamond, A. D. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa276 · Cited by 20
Bad habits–good goals? Meta-analysis and translation of the habit construct to alcoholism
Giannone, F., Ebrahimi, C., Endraß, T., Hansson, A. C., Schlagenhauf, F., & Sommer, W. H. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02965-1 · Cited by 21
Dopaminergic medication counteracts conflict adaptation in patients with Parkinson’s disease.
Duthoo, W., Braem, S., Houtman, F., Schouppe, N., Santens, P., & Notebaert, W. (2013) · Neuropsychology · doi:10.1037/a0033377 · Cited by 20
Cognitive Control and Schizophrenia: Psychological and Neural Mechanisms
Barch, D. M., & Braver, T. S. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511720413.007 · Cited by 21
Schulz, S., Arning, L., Pinnow, M., Wascher, E., Epplen, J. T., & Beste, C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.012 · Cited by 21
D’Esposito, M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)88011-0 · Cited by 21
Healthy aging increases the cognitive effects of two genes that influence extracellular dopamine.
Greenwood, P. M., Lin, M., Sundararajan, R., Fryxell, K. J., & Parasuraman, R. (2014) · Psychology and Aging · doi:10.1037/a0036109 · Cited by 21
Barkus, C., Korn, C., Stumpenhorst, K., Laatikainen, L. M., Ballard, D., Lee, S., Sharp, T., Harrison, P. J., Bannerman, D. M., Weinberger, D. R., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.119 · Cited by 20
Self-citationEllis, K. A., Mehta, M. A., Wesnes, K. A., Armstrong, S., & Nathan, P. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0019-2 · Cited by 20
Li, H., & Jin, X. (2023) · eLife · doi:10.7554/elife.87644 · Cited by 22
Blair, C., Sulik, M. J., Willoughby, M. T., Mills-Koonce, R., Petrill, S. A., Bartlett, C. W., Greenberg, M. T., & the Family Life Project Investigators (2015) · Developmental Psychobiology · doi:10.1002/dev.21332 · Cited by 20
COMT Val158Met Polymorphism Modulates Cognitive Effects of Dietary Intervention
Witte, A. V., Jansen, S., Schirmacher, A., Young, P., & Flöel, A. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00146 · Cited by 19
Leerkes, E. M., Gedaly, L. R., Zhou, N., Calkins, S. D., Henrich, V. C., & Smolen, A. (2016) · Attachment & Human Development · doi:10.1080/14616734.2016.1253759 · Cited by 19
Dopamine and Working Memory: Genetic Variation, Stress and Implications for Mental Health
Klaus, K., & Pennington, K. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_113 · Cited by 20
Fremont, R., Manoochehri, M., Armstrong, N. M., Mattay, V. S., Apud, J. A., Tierney, M. C., Devanand, D. P., Gazes, Y., Habeck, C. G., Wassermann, E. M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191265 · Cited by 19
Self-citationChan, K. K. S., Hui, C. L. M., Lam, M. M. L., Tang, J. Y. ‐., Wong, G. H. Y., Chan, S. K. W., & Chen, E. Y. H. (2010) · PubMed · Cited by 19
5 Dopaminergic Modulation of Cognition in Human Aging
Li, S., Lindenberger, U., Nyberg, L. H., Heekeren, H. R., & Bäckman, L. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0005 · Cited by 20
PET neuroimaging of extrastriatal dopamine receptors and prefrontal cortex functions
Takahashi, H. (2013) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2013.07.001 · Cited by 19
Xu, J., Qin, W., Liu, B., Jiang, T., & Yu, C. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1134-4 · Cited by 18
Tolcapone,COMTPolymorphisms and Pharmacogenomic Treatment of Schizophrenia
Bitsios, P., & Roussos, P. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.206 · Cited by 18
Hall, K. T., Tolkin, B. R., Chinn, G. M., Kirsch, I., Kelley, J. M., Lembo, A. J., Kaptchuk, T. J., Kokkotou, E. G., Davis, R. B., & Conboy, L. A. (2014) · Brain and Behavior · doi:10.1002/brb3.294 · Cited by 18
Murphy, A., Dursun, S. M., McKie, S., Elliott, R., & Deakin, J. F. W. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4234-9 · Cited by 18
Turner, K. M., Peak, J. N., & Burne, T. H. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00437-9 · Cited by 18
The influence of COMT rs4680 on functional connectivity in healthy adults: A systematic review
Morris, K. A., Grace, S., Woods, W., Dean, B., & Rossell, S. L. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14748 · Cited by 18
Abraham, E., Scott, M. A., & Blair, C. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00724 · Cited by 18
Shimada, K., Fujisawa, T. X., Takiguchi, S., Naruse, H., Kosaka, H., Okazawa, H., & Tomoda, A. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1102325 · Cited by 18
Schilt, T., Koeter, M. W. J., de Win, M. M. L., Zinkstok, J., van Amelsvoort, T., Schmand, B. A., & van den Brink, W. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.10.004 · Cited by 18
Functional Imaging Research in Schizophrenia
Tost, H., Ende, G., Ruf, M., Henn, F. A., & Meyer‐Lindenberg, A. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)67004-3 · Cited by 18
Chapter 4 Functional neuroimaging of cognition
Perani, D. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)88004-3 · Cited by 17
Peterson, E., Møller, A., Doudet, D. J., Bailey, C. J., Hansen, K. V., Rodell, A. B., Linnet, J., & GJEDDE, A. H. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.07.010 · Cited by 17
Less Cognitive and Neurological Deficits in Schizophrenia Patients Carrying Risk Variant in ZNF804A
Bossche, M. J. A. V. D., Docx, L., Morrens, M., Cammaerts, S., Stražišar, M., Bervoets, C., Smolders, S., Depreeuw, V., Lenaerts, A., Rijk, P. D., et al. (2012) · Neuropsychobiology · doi:10.1159/000339731 · Cited by 17
Swerdlow, N. R., Bhakta, S. G., Talledo, J., Franz, D. M., Hughes, E., Rana, B. K., & Light, G. A. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.285 · Cited by 17
Hennessey, E. P., Kepinska, O., Haft, S. L., Chan, M., Sunshine, I., Jones, C. L., Hancock, R., & Hoeft, F. (2020) · Biological Psychology · doi:10.1016/j.biopsycho.2020.107946 · Cited by 23
Strategies for pharmacotherapy of schizophrenia
Arnt, J., Bang‐Andersen, B., Dias, R. D. S., & Bøgesø, K. P. (2008) · Drugs of the Future · doi:10.1358/dof.2008.033.09.1236966 · Cited by 17
Stuart, K. E., Summers, M. J., Valenzuela, M., & Vickers, J. C. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.01.013 · Cited by 17
Effects of COMT Genotypes on Working Memory Performance in Fibromyalgia Patients
Ferrera, D., Gómez‐Esquer, F., Peláez, I., Barjola, P., Fernandes-Magalhaes, R., Carpio, A., Lahoz, M. E. D., Díaz‐Gil, G., & Mercado, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082479 · Cited by 20
Pharmacogenetic Approaches to Cognitive Enhancement in Schizophrenia
Burdick, K. E., Gopin, C. B., & Malhotra, A. K. (2011) · Harvard Review of Psychiatry · doi:10.3109/10673229.2011.581899 · Cited by 16
Effects of PPP1R1B (DARPP-32) Polymorphism on Feedback-Related Brain Potentials Across the Life Span
Hämmerer, D., Biele, G., Müller, V., Thiele, H., Nürnberg, P., Heekeren, H. R., & Li, S. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00089 · Cited by 16
Biological Treatments for Amfetamine Dependence
Hill, K. P., & Sofuoglu, M. (2007) · CNS Drugs · doi:10.2165/00023210-200721100-00005 · Cited by 16
Li, X., Bäckman, L., & Persson, J. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.022 · Cited by 18
Saloner, R., Cherner, M., Sundermann, E. E., Watson, C. W., Iudicello, J. E., Letendre, S. L., Kumar, A. M., & Ellis, R. J. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113269 · Cited by 16
Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine
Bousman, C. (2010) · Neurobehavioral HIV Medicine · doi:10.2147/nbhiv.s8245 · Cited by 16
Salience of working-memory maintenance and manipulation deficits in schizophrenia
Hill, S. K., Griffin, G. B., Miura, T. K., Herbener, E. S., & Sweeney, J. A. (2010) · Psychological Medicine · doi:10.1017/s003329171000019x · Cited by 16
Sase, A., Aher, Y. D., Saroja, S. R., Ganesan, M. K., Sase, S., Holy, M., Höger, H., Bakulev, V. A., Ecker, G. F., Langer, T., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.039 · Cited by 15
Chavanon, M., Wacker, J., Leue, A., & Stemmler, G. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2006.07.001 · Cited by 19
Magalona, S., Rasetti, R., Chen, J., Chen, Q., Gold, I., Decot, H., Callicott, J. H., Berman, K. F., Apud, J. A., Weinberger, D. R., et al. (2013) · CNS Drugs · doi:10.1007/s40263-013-0082-x · Cited by 16
Self-citationKaurijoki, S., Kuikka, J. T., Niskanen, E. I., Carlson, S., Pietiläinen, K. H., Pesonen, U., Kaprio, J. A., Rissanen, A., Tiihonen, J., & Karhunen, L. J. (2008) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2008.00804.x · Cited by 16
Neuroscience of Drugs and Addiction
Robbins, T. W., Cardinal, R. N., Ciano, P. D., Halligan, P. W., Hellemans, K., Lee, J. L. C., & Everitt, B. J. (2007) · Elsevier eBooks · doi:10.1016/b978-012370624-9/50006-2 · Cited by 16
Smelson, D., Yu, L., Buyske, S., Gonzalez, G., Tischfield, J., Deutsch, C. K., & Ziedonis, D. (2012) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2012.00253.x · Cited by 15
Sex and the dopaminergic system: Insights from addiction studies
Woodcock, E. A., Zakiniaeiz, Y., Morris, E. D., & Cosgrove, K. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00011-4 · Cited by 15
Jaspar, M., Dideberg, V., Bours, V., Maquet, P., & Collette, F. (2015) · Brain and Cognition · doi:10.1016/j.bandc.2015.01.013 · Cited by 15
Smith, C. T., Swift‐Scanlan, T., & Boettiger, C. A. (2013) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00501 · Cited by 15
Improvement of attention with amphetamine in low- and high-performing rats
Turner, K. M., & Burne, T. H. J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4376-9 · Cited by 15
Metadata
- Authors
- Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-04-25
- Volume
- 100
- Issue
- 10
- Pages
- 6186-6191
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC156347
- OpenAlex
- W2123636362
- Cited by
- 893
- References
- 36
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 10 · 2020: 19 · 2019: 13 · 2018: 17 · 2017: 30 · 2016: 34 · 2015: 51 · 2014: 50 · 2013: 66 · 2012: 61
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- catechol-O-methyltransferase, COMT Val158Met polymorphism, amphetamine, prefrontal cortex, working memory, dopamine signaling, pharmacogenomics, individual differences, monoaminergic systems
- MeSH terms
- Brain, Catechol O-Methyltransferase, Dextroamphetamine, DNA, Genotype, Humans, Magnetic Resonance Imaging, Methionine, Organ Specificity, Valine, Amino Acid Substitution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review